BIOMAT Database Logo BIOMAT Database Logo

[Effectiveness and tolerance of amitriptyline oxide in chronic tension headache--a multicenter double-blind study versus amitriptyline versus placebo]. 1993

V Pfaffenrath, and H C Diener, and H Isler, and C Meyer, and E Scholz, and Z Taneri, and P Wessely, and H Zaiser-Kaschel, and W Haase, and W Fischer
Neurologische Praxis, München.

Tricyclic antidepressants, especially amitriptyline, are the medication of first choice in the treatment of chronic tension headache. Few previous studies meet modern standards of study design and statistical analysis. Tolerability and efficacy of 60-90 mg amitriptyline oxide (AO) as a single dose in the evening were compared with 50-75 mg amitriptyline (AM) and placebo (PL) in a double-blind, parallel-group trial consisting of a 4-week baseline phase and 12 weeks of treatment. The 3-armed study was conducted in 7 centers. The inclusion criterion was tension-type headache on at least 15 days monthly with a duration of at least 6 months. Exclusion criteria were a migraine history, previous participation in another clinical trial within the last 3 months, drug abuse, medication with other antidepressants or tranquilizers, current use of other acknowledged prophylactic headache medication, lack of compliance, major psychiatric disorder according to DSM-III and medical contra-indications against tricyclic antidepressants. The primary study endpoint was a reduction at least 50% of the product of headache duration and frequency and a reduction at least 50% in headache intensity. Statistics used were Fisher's Exact Test and an analysis of variance. A total of 211 patients were included in this trial. One hundred ninety-seven cases, 87 males and 110 females, with a mean age of 38 +/- 13 (18-68) years, could be analysed completely (66 AO, 67 AM, 64 PL). With regard to the strictly defined primary study endpoint, no significant difference emerged between AO, AM and PL: treatment responders were 30.3% with AO, 22.4% with AM and 21.9% with PL (PAO-PL = 0.3210, PAM-PL = 1.000, PAO-AM = 0.3299 respectively).(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D005260 Female Females
D006261 Headache The symptom of PAIN in the cranial region. It may be an isolated benign occurrence or manifestation of a wide variety of HEADACHE DISORDERS. Cephalgia,Hemicrania,Bilateral Headache,Cephalalgia,Cephalodynia,Cranial Pain,Generalized Headache,Head Pain,Ocular Headache,Orthostatic Headache,Periorbital Headache,Retro-Ocular Headache,Sharp Headache,Throbbing Headache,Unilateral Headache,Vertex Headache,Bilateral Headaches,Cephalalgias,Cephalgias,Cephalodynias,Cranial Pains,Generalized Headaches,Head Pains,Headache, Bilateral,Headache, Generalized,Headache, Ocular,Headache, Orthostatic,Headache, Periorbital,Headache, Retro-Ocular,Headache, Sharp,Headache, Throbbing,Headache, Unilateral,Headache, Vertex,Headaches,Headaches, Bilateral,Headaches, Generalized,Headaches, Ocular,Headaches, Orthostatic,Headaches, Periorbital,Headaches, Retro-Ocular,Headaches, Sharp,Headaches, Throbbing,Headaches, Unilateral,Headaches, Vertex,Ocular Headaches,Orthostatic Headaches,Pain, Cranial,Pain, Head,Pains, Cranial,Pains, Head,Periorbital Headaches,Retro Ocular Headache,Retro-Ocular Headaches,Sharp Headaches,Throbbing Headaches,Unilateral Headaches,Vertex Headaches
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

V Pfaffenrath, and H C Diener, and H Isler, and C Meyer, and E Scholz, and Z Taneri, and P Wessely, and H Zaiser-Kaschel, and W Haase, and W Fischer
[Effectiveness of flupirtine in chronic tension headache. Results of a double-blind study versus placebo].
November 1995, Fortschritte der Medizin,
V Pfaffenrath, and H C Diener, and H Isler, and C Meyer, and E Scholz, and Z Taneri, and P Wessely, and H Zaiser-Kaschel, and W Haase, and W Fischer
[Effectiveness of flunarizine in chronic headache. Double-blind study of placebo and amitriptyline].
December 1985, La Clinica terapeutica,
V Pfaffenrath, and H C Diener, and H Isler, and C Meyer, and E Scholz, and Z Taneri, and P Wessely, and H Zaiser-Kaschel, and W Haase, and W Fischer
Chronic tension headache--treated with amitriptyline--a double-blind study.
October 1971, Headache,
V Pfaffenrath, and H C Diener, and H Isler, and C Meyer, and E Scholz, and Z Taneri, and P Wessely, and H Zaiser-Kaschel, and W Haase, and W Fischer
Treatment of chronic tension-type headache with botulinum toxin A: a randomized, double-blind, placebo-controlled multicenter study.
May 2004, Pain,
V Pfaffenrath, and H C Diener, and H Isler, and C Meyer, and E Scholz, and Z Taneri, and P Wessely, and H Zaiser-Kaschel, and W Haase, and W Fischer
Tizanidine in chronic tension-type headache: a placebo controlled double-blind cross-over study.
November 1992, Headache,
V Pfaffenrath, and H C Diener, and H Isler, and C Meyer, and E Scholz, and Z Taneri, and P Wessely, and H Zaiser-Kaschel, and W Haase, and W Fischer
Chronic daily headache prophylaxis with tizanidine: a double-blind, placebo-controlled, multicenter outcome study.
June 2002, Headache,
V Pfaffenrath, and H C Diener, and H Isler, and C Meyer, and E Scholz, and Z Taneri, and P Wessely, and H Zaiser-Kaschel, and W Haase, and W Fischer
Effervescent ASA versus solid ASA in the treatment of tension headache. A double-blind, placebo controlled study.
February 1987, Headache,
V Pfaffenrath, and H C Diener, and H Isler, and C Meyer, and E Scholz, and Z Taneri, and P Wessely, and H Zaiser-Kaschel, and W Haase, and W Fischer
Pressure pain threshold and needle acupuncture in chronic tension-type headache--a double-blind placebo-controlled study.
November 2000, Pain,
V Pfaffenrath, and H C Diener, and H Isler, and C Meyer, and E Scholz, and Z Taneri, and P Wessely, and H Zaiser-Kaschel, and W Haase, and W Fischer
Maprotiline in chronic tension headache: a double-blind cross-over study.
July 1985, Headache,
V Pfaffenrath, and H C Diener, and H Isler, and C Meyer, and E Scholz, and Z Taneri, and P Wessely, and H Zaiser-Kaschel, and W Haase, and W Fischer
Amitriptyline treatment in chronic drug-induced headache: a double-blind comparative pilot study.
February 2001, Headache,
Copied contents to your clipboard!